The PK Protocol aids in regeneration of the cell membrane to treat neurotoxicity in order to treat the following:
-ALS, Motor Neuron Disease
-Autism and Developmental Delay
-Chronic Fatigue Syndrome
-Heavy metal detoxification
-Hyperlipidemia (elevated cholesterol, LDL, triglycerides)
-Inherited Metabolic Disorders
How The Protocol Is Implemented:
- The patient comes into the office for a blood draw for the following tests: blood chemistry and Red Blood Cell Analysis, which is sent to the Kennedy Kreiger Institute for an in-depth analysis.
- Your blood test results will then be sent to BodyBio for analysis that includes screening for Cardiac Risk, Cellular Distortion, Electrolyte Stability, Gastrointestinal Function, Hematology, Hepatic Function, Immune Status, Lipid Metabolism, Muscular Involvement, Nitrogen Retention, Psychological Stability, Physiological Stability, Pulmonary Function, Renal Function and Toxicity Status. Each of these systems will be reviewed to isolate the areas requiring intervention.
- You will then receive a personalized Fatty Acid Report, Fatty Acid Analysis, IV Protocol and Nutrient Protocol--recommendations for supplements such as electrolytes, minerals, enzymes, fatty acids, vitamins and amino acids. These protocols are tailored to you to address your specific needs.
- You will meet with Dr. DeLuca to review your reports and protocols and receive a personalized treatment plan.
The Patricia Kane (PK) Protocol and BodyBio Testing
BodyBio Inc. is one of only a few organizations in the world that has been able to keep pace with the available medical research on the implications of nutrition on functions and disorders. Even more importantly, BodyBio has developed proven methods (our diagnostic BodyBio Reports) to bridge the knowledge gap between applied nutritional research, health care practitioners and patients interested in nutrition as a component of their health care.
The PK -Membrane Stabilizing- Protocol for Neurological Disorders
Background: The lipid soluble nature of toxicity has led us to seize the complexity of neurological presentations by addressing them from a cell membrane perspective. Examination of red cell lipids and identification of nuclear DNA adducts as chemicals, pesticides, microbials and metals in subjects with Motor Neuron Disease, Autism, Multiple Sclerosis, Post Stroke, Epilepsy, Alzheimer’s and Parkinson’s Disease over the past eleven years in 9000 analyses has revealed a characteristic accumulation of very long chain fatty acids (VLCFAs), which comprise lipid rafts, or ceramides, revealing cell membrane derangement. Membrane phospholipid abnormalities with elevation of VLCFAs may be indicative of exposure to fat soluble neurotoxins resulting in suppressed peroxisomal beta oxidation of VLCFAs. Disturbances in methylation due to toxic exposure may destabilize the membrane phospholipid structure and alter DNA expression due to deficits in the enzymes Methylene Tetrahydrofolate Reductase (MTHFR) and Methionine Synthase.
Objective: The use of oral and IV lipids may facilitate stabilization of phospholipids in cellular membranes thereby addressing cell membrane integrity. The addition of intravenous phenylbutrate addresses neuroinflammation by increasing the beta oxidation of VLCFAs.
Procedure: To clear the bioaccumulation of toxins and stabilize membrane function we have embarked on a clinical treatment plan for the past five years to address the accumulation of aberrant lipids and ceramides with oral and IV phenylbutyrate, bolus intravenous phosphatidylcholine as Essentiale, methylation factors (folinic acid, riboflavin, methylcobalamin, tetrahydrobiopterin), and sulfation support (IV Glutathione).
Results: We have noted significant and sustained clinical neurological improvement within the first few weeks after initiation of oral and intravenous treatment in our patient population of 300 subjects.
Conclusion: The administration of Phosphatidylcholine, Leucovorin/Folinic acid, Glutathione and Phenylbutyrate may offer a new therapeutic strategy for neurological disorders involving neurotoxic exposure.
So you might be thinking: how can one treatment regimen work on so many different diseases? While there are a few root causes of acquired disease --among them toxins, infections and trauma-- the final common pathways of disease are all due to cellular damage and dysfunction. This can happen at the cell membrane, the DNA, or the mitochondria (some of you may have to harken back to high school biology class). So, very briefly, what the PK Protocol does is remove the accumulated toxins in and on the cells and introduces back the raw materials to repair the membranes. That process allows function to be restored. This is a very simple, yet profoundly complicated process. So what organs are damaged enough to impair function gives you your diagnosis, the protocol helps repair all the cells of the body, which is why it's applicable to Age Management (some of our patients got to meet Ed Kane, Dr. Kane's husband, who is 85, sharp as a tack, and lectures to physicians in the seminars).
I took my first PK Protocol raining in June and got so much out of the seminar, I will be returning for more training in April. We had the distinct privilege of having Dr. Kane recently spend time in the office, personally training our staff and meeting with some patients (not to mention giving me my first treatment).
I urge you to go pkprotocol.com or BodyBio.com for more information. Or you can come by the office and see my BodyBio report, lab results and treatment plan. Some of the case reports are up on our walls.